Sonographic abnormality of the substantia nigra in melanoma patients.
about
Monoamine reuptake inhibitors in Parkinson's disease.Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma.Structural abnormality of substantia nigra induced by methamphetamine abuse.Light pigmentation phenotype is correlated with increased substantia nigra echogenicity.Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms
P2860
Sonographic abnormality of the substantia nigra in melanoma patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Sonographic abnormality of the substantia nigra in melanoma patients.
@en
Sonographic abnormality of the substantia nigra in melanoma patients.
@nl
type
label
Sonographic abnormality of the substantia nigra in melanoma patients.
@en
Sonographic abnormality of the substantia nigra in melanoma patients.
@nl
prefLabel
Sonographic abnormality of the substantia nigra in melanoma patients.
@en
Sonographic abnormality of the substantia nigra in melanoma patients.
@nl
P2093
P2860
P356
P1433
P1476
Sonographic abnormality of the substantia nigra in melanoma patients.
@en
P2093
Christopher Fricke
David Weise
Jan-Christoph Simon
Joseph Classen
Jost-Julian Rumpf
Tino Wetzig
P2860
P304
P356
10.1002/MDS.25233
P407
P577
2012-10-31T00:00:00Z